Literature DB >> 21511893

Protective effect of chrysin on carbon tetrachloride (CCl4)-induced tissue injury in male Wistar rats.

Kalaiselvi Velayutham Anand1, Ramalingam Anandhi, Murugesan Pakkiyaraj, Pitchairaj Geraldine.   

Abstract

Chrysin, a natural flavonoid has been reported to possess potent anti-inflammatory, anti-cancer and antioxidation properties. In the present study, we aimed to evaluate the putative protective effect of chrysin, an isoflavone, on carbon tetrachloride (CCl(4))-induced toxicity in male Wistar rats. Intraperitoneal administration of CCl(4) (2 ml/kg) to rats for 4 days resulted in significantly elevated (p < 0.05) serum levels of glutamic oxaloacetic transaminase (SGOT), glutamic pyruvate transaminase (SGPT), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH), when compared to normal rats. In addition, the tissues (liver, kidney and brain) and haemolysate samples showed considerable increase in levels (p < 0.05) of malondialdehyde (MDA) and lowered levels (p < 0.05) of reduced glutathione (GSH), vitamin C and E when compared to values in normal rats. Quantitative analysis of catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (Gpx) exhibited lower activities of these antioxidant enzymes in the tissues and haemolysate of CCl(4)-administered rats. The protective action of chrysin on CCl(4)-induced rat was demonstrated with SGPT, SGOT, ALP and LDH resuming to near normal levels, while the mean levels of GSH and of vitamin C and E were elevated, the mean activities of CAT, SOD and Gpx were enhanced and the mean level of MDA was lowered in the tissue and haemolysate samples when compared to the CCl(4)-exposed untreated rats. The expression of the iNOS gene appeared to be up-regulated in the liver and kidney samples of CCl(4)-exposed untreated rats, whereas in CCl(4)-exposed chrysin-treated rats, the mRNA transcript levels of iNOS approximated normal levels. These results strongly suggest that chrysin is able to prevent the oxidative damage induced by CCl(4) in the liver, brain, kidney and haemolysate of male Wistar rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511893     DOI: 10.1177/0748233711399324

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  13 in total

1.  Ameliorative impacts of chrysin against gibberellic acid-induced liver and kidney damage through the regulation of antioxidants, oxidative stress, inflammatory cytokines, and apoptosis biomarkers.

Authors:  Mohamed Mohamed Soliman; Adil Aldhahrani; Ahmed Gaber; Walaa F Alsanie; Wafaa Abdou Mohamed; Mohamed M M Metwally; Mohamed Elbadawy; Mustafa Shukry
Journal:  Toxicol Res (Camb)       Date:  2022-02-03       Impact factor: 3.524

2.  Chrysin ameliorates nonalcoholic fatty liver disease in rats.

Authors:  Sarayu A Pai; Renuka P Munshi; Falguni H Panchal; Ila-Shruti Gaur; Archana R Juvekar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-01       Impact factor: 3.000

3.  Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats.

Authors:  Ramalingam Anandhi; Thangaraj Annadurai; Thirugnanasambandhar S Anitha; Arumugam R Muralidharan; Kalifulla Najmunnisha; Vasanthi Nachiappan; Philip A Thomas; Pitchairaj Geraldine
Journal:  J Physiol Biochem       Date:  2012-10-27       Impact factor: 4.158

4.  Reducing the oxidative stress mediates the cardioprotection of bicyclol against ischemia-reperfusion injury in rats.

Authors:  Jie Cui; Zhi Li; Ling-bo Qian; Qin Gao; Jue Wang; Meng Xue; Xiao-e Lou; Iain C Bruce; Qiang Xia; Hui-ping Wang
Journal:  J Zhejiang Univ Sci B       Date:  2013-06       Impact factor: 3.066

5.  Chrysin attenuates traumatic brain injury-induced recognition memory decline, and anxiety/depression-like behaviors in rats: Insights into underlying mechanisms.

Authors:  Masome Rashno; Shahab Ghaderi; Ali Nesari; Layasadat Khorsandi; Yaghoob Farbood; Alireza Sarkaki
Journal:  Psychopharmacology (Berl)       Date:  2020-02-22       Impact factor: 4.530

6.  Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats.

Authors:  Badreldin H Ali; Sirin A Adham; Mohammed Al Za'abi; Mostafa I Waly; Javed Yasin; Abderrahim Nemmar; Nicole Schupp
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

Review 7.  Protective Effects of Chrysin Against Drugs and Toxic Agents.

Authors:  Saeed Samarghandian; Tahereh Farkhondeh; Mohsen Azimi-Nezhad
Journal:  Dose Response       Date:  2017-06-23       Impact factor: 2.658

8.  Acetonic and Methanolic Extracts of Heterotheca inuloides, and Quercetin, Decrease CCl(4)-Oxidative Stress in Several Rat Tissues.

Authors:  Elvia Coballase-Urrutia; José Pedraza-Chaverri; Noemí Cárdenas-Rodríguez; Bernardino Huerta-Gertrudis; Mercedes Edna García-Cruz; Hortencia Montesinos-Correa; Dolores Javier Sánchez-González; Rafael Camacho-Carranza; Jesús Javier Espinosa-Aguirre
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-10       Impact factor: 2.629

9.  Hepatoprotective activity of chrysin is mediated through TNF-α in chemically-induced acute liver damage: An in vivo study and molecular modeling.

Authors:  Anca Hermenean; Teodora Mariasiu; Inmaculada Navarro-González; Josefina Vegara-Meseguer; Eftimie Miuțescu; Sandipan Chakraborty; Horacio Pérez-Sánchez
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

10.  Dose-Dependent Antifibrotic Effect of Chrysin on Regression of Liver Fibrosis: The Role in Extracellular Matrix Remodeling.

Authors:  Cornel Balta; Alina Ciceu; Hildegard Herman; Marcel Rosu; Oana Maria Boldura; Anca Hermenean
Journal:  Dose Response       Date:  2018-08-08       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.